Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
2019 · Journal of the National Comprehensive Cancer Network · 432 citations
https://doi.org/10.6004/jnccn.2019.0018
A
Anjela Galan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
100
Papers
2.8K
Citations
24
h-index
46
i10-index
Anjela Galan is an academic researcher from Yale New Haven Hospital. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Immunotherapy and Immune Responses & Melanoma and MAPK Pathways. The author has an h-index of 24, co-authored 85 publications.
ORCID: 0000-0001-5620-801XPapers by this author
worksNCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
2021 · Journal of the National Comprehensive Cancer Network · 327 citations
https://doi.org/10.6004/jnccn.2021.0018
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
2024 · Journal of the National Comprehensive Cancer Network · 100 citations
https://doi.org/10.6004/jnccn.2024.0036
Melanoma in situ
2015 · Journal of the American Academy of Dermatology · 93 citations
https://doi.org/10.1016/j.jaad.2015.04.014
Melanoma in situ
2015 · Journal of the American Academy of Dermatology · 76 citations
https://doi.org/10.1016/j.jaad.2015.03.057
Bacterial infections in patients hospitalized with COVID-19
2021 · Internal and Emergency Medicine · 48 citations
https://doi.org/10.1007/s11739-021-02824-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat